Detection of COVID-19 Using Breath Analysis - Validation Study.
NCT ID: NCT05224622
Last Updated: 2023-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
192 participants
INTERVENTIONAL
2022-01-18
2023-01-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of COVID-19 Using Breath Analysis - Validation Study
NCT04602949
Detection of Bacterial and Viral Pathogens Infection Among Hospitalized Patients Feasibility Study
NCT05399615
Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis
NCT04842708
The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19
NCT06571136
Covid-19 Breath Test
NCT04459962
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary objective- To validate the value of a set of breath VOC biomarkers that enable the investigator to distinguish between COVID-19 carriers and COVID-19 non-carriers in comparison to the gold-standard testing methodology.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Drive In
Drive In attendees will undergo one breath sampling.
VOX
Breath exhalation into the mouthpiece of the VOX breath diagnostic device.
Healthy
Healthy attendees will undergo two successive breath sampling.
VOX
Breath exhalation into the mouthpiece of the VOX breath diagnostic device.
Corona Department
Healthy attendees will undergo five successive breath sampling.
VOX
Breath exhalation into the mouthpiece of the VOX breath diagnostic device.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VOX
Breath exhalation into the mouthpiece of the VOX breath diagnostic device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable of understanding written and/or spoken language
* Able to provide informed consent
* Was not treated with Anti-viral drugs
Exclusion Criteria
* Under guardianship or deprived of liberty
* Pregnant or lactating woman
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Scentech Medical Technologies Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Avi Peretz, PhD
Role: PRINCIPAL_INVESTIGATOR
Poriya Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Poriya Medical Center
Poria – Neve Oved, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COV-2-PMC-2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.